← Back to Search

Diagnostic Test

VExUS score for Sepsis (DRI-US Trial)

N/A
Waitlist Available
Led By Keith Corl, MD
Research Sponsored by The Miriam Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28 days and during hospital admission up to 24 weeks
Awards & highlights

DRI-US Trial Summary

This study is evaluating whether a new method of fluid resuscitation can reduce fluid overload in critically ill patients with sepsis.

Eligible Conditions
  • Volume Overload
  • Sepsis
  • Septic Shock

DRI-US Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28 days and during hospital admission up to 24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 28 days and during hospital admission up to 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cumulative Fluid Balance at 5 days post ICU discharge or ICU Discharge
Secondary outcome measures
28-day and in-hospital mortality
Change in SOFA score
Daily Sonographic B Line Measurement
+3 more

DRI-US Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: VExUS-Guided ArmExperimental Treatment1 Intervention
Will receive 24 hour fluid balance target based on daily VExUS score.
Group II: Usual Care Control ArmActive Control1 Intervention
Treating team will be blinded to results of daily VExUS score and will set 24 hour fluid balance target based on usual care.

Find a Location

Who is running the clinical trial?

The Miriam HospitalLead Sponsor
238 Previous Clinical Trials
37,323 Total Patients Enrolled
Keith Corl, MDPrincipal InvestigatorRhode Island Hospital / The Miriam Hospital
1 Previous Clinical Trials
113 Total Patients Enrolled
1 Trials studying Sepsis
113 Patients Enrolled for Sepsis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~39 spots leftby Apr 2025